XENE - Xenon Pharmaceuticals Inc

Healthcare - Sector
Coverage

XENE is currently covered by 7 analysts with average potential upside of $9.55 (53.55%) backed by 22 price targets and 65 ratings. Analyst's average stock valuation to be materialised ratio is 56.67% with an average time for price targets to be met of 457.7 days.

Most recent stock forecast was given by YATIN SUNEJA from GUGGENHEIM on 11-Nov-2022.

Highest price target for XENE is 40, Lowest price target is 16, average price target is 28.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

49

$11.35 (30.15%)

45

2 months 18 days ago

0/2 (0%)

$14.05 (42.63%)

Buy

49

$11.35 (30.15%)

46

3 months 18 days ago

2/6 (33.33%)

$9.11 (45.11%)

702

Buy

46

$8.35 (22.18%)

40

5 months 18 days ago

2/4 (50%)

$6.95 (37.56%)

256

Buy

41

$3.35 (8.90%)

46

7 months 2 days ago

1/4 (25%)

$12.14 (55.10%)

558

Buy

48

$10.35 (27.49%)

48

7 months 6 days ago

2/6 (33.33%)

$13.3 (50.65%)

328

Show more analysts